TETRACYCLIC COMPOUND

A compound represented by the general Formula (I) below, or a salt or solvate thereof, which is useful as an ALK inhibitor, and is useful for prophylaxis or treatment of a disease accompanied by abnormality in ALK, for example, cancer, cancer metastasis, depression or cognitive function disorder:(me...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KAWADA, HATSUO, ISHII, NOBUYA, PARK, MINJEONG, KINOSHITA, KAZUTOMO, FURUICHI, NORIYUKI, ONO, YOSHIYUKI, EMURA, TAKASHI, SAKAMOTO, HIROSHI, KATO, YASUHARU, ASOH, KOHSUKE, ITO, TOSHIYA, MORIKAMI, KENJI, OIKAWA, NOBUHIRO, HONG, WOOSANG
Format: Patent
Sprache:eng ; srp
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KAWADA, HATSUO
ISHII, NOBUYA
PARK, MINJEONG
KINOSHITA, KAZUTOMO
FURUICHI, NORIYUKI
ONO, YOSHIYUKI
EMURA, TAKASHI
SAKAMOTO, HIROSHI
KATO, YASUHARU
ASOH, KOHSUKE
ITO, TOSHIYA
MORIKAMI, KENJI
OIKAWA, NOBUHIRO
HONG, WOOSANG
description A compound represented by the general Formula (I) below, or a salt or solvate thereof, which is useful as an ALK inhibitor, and is useful for prophylaxis or treatment of a disease accompanied by abnormality in ALK, for example, cancer, cancer metastasis, depression or cognitive function disorder:(meanings of the symbols that are included in the formula are as given in the specification).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RS58855B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RS58855B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RS58855B13</originalsourceid><addsrcrecordid>eNrjZBAJcQ0JcnSOdPbxdFZw9vcN8A_1c-FhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfFBwaYWFqamTobGBBUAAN6pHbs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TETRACYCLIC COMPOUND</title><source>esp@cenet</source><creator>KAWADA, HATSUO ; ISHII, NOBUYA ; PARK, MINJEONG ; KINOSHITA, KAZUTOMO ; FURUICHI, NORIYUKI ; ONO, YOSHIYUKI ; EMURA, TAKASHI ; SAKAMOTO, HIROSHI ; KATO, YASUHARU ; ASOH, KOHSUKE ; ITO, TOSHIYA ; MORIKAMI, KENJI ; OIKAWA, NOBUHIRO ; HONG, WOOSANG</creator><creatorcontrib>KAWADA, HATSUO ; ISHII, NOBUYA ; PARK, MINJEONG ; KINOSHITA, KAZUTOMO ; FURUICHI, NORIYUKI ; ONO, YOSHIYUKI ; EMURA, TAKASHI ; SAKAMOTO, HIROSHI ; KATO, YASUHARU ; ASOH, KOHSUKE ; ITO, TOSHIYA ; MORIKAMI, KENJI ; OIKAWA, NOBUHIRO ; HONG, WOOSANG</creatorcontrib><description>A compound represented by the general Formula (I) below, or a salt or solvate thereof, which is useful as an ALK inhibitor, and is useful for prophylaxis or treatment of a disease accompanied by abnormality in ALK, for example, cancer, cancer metastasis, depression or cognitive function disorder:(meanings of the symbols that are included in the formula are as given in the specification).</description><language>eng ; srp</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190731&amp;DB=EPODOC&amp;CC=RS&amp;NR=58855B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190731&amp;DB=EPODOC&amp;CC=RS&amp;NR=58855B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KAWADA, HATSUO</creatorcontrib><creatorcontrib>ISHII, NOBUYA</creatorcontrib><creatorcontrib>PARK, MINJEONG</creatorcontrib><creatorcontrib>KINOSHITA, KAZUTOMO</creatorcontrib><creatorcontrib>FURUICHI, NORIYUKI</creatorcontrib><creatorcontrib>ONO, YOSHIYUKI</creatorcontrib><creatorcontrib>EMURA, TAKASHI</creatorcontrib><creatorcontrib>SAKAMOTO, HIROSHI</creatorcontrib><creatorcontrib>KATO, YASUHARU</creatorcontrib><creatorcontrib>ASOH, KOHSUKE</creatorcontrib><creatorcontrib>ITO, TOSHIYA</creatorcontrib><creatorcontrib>MORIKAMI, KENJI</creatorcontrib><creatorcontrib>OIKAWA, NOBUHIRO</creatorcontrib><creatorcontrib>HONG, WOOSANG</creatorcontrib><title>TETRACYCLIC COMPOUND</title><description>A compound represented by the general Formula (I) below, or a salt or solvate thereof, which is useful as an ALK inhibitor, and is useful for prophylaxis or treatment of a disease accompanied by abnormality in ALK, for example, cancer, cancer metastasis, depression or cognitive function disorder:(meanings of the symbols that are included in the formula are as given in the specification).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBAJcQ0JcnSOdPbxdFZw9vcN8A_1c-FhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfFBwaYWFqamTobGBBUAAN6pHbs</recordid><startdate>20190731</startdate><enddate>20190731</enddate><creator>KAWADA, HATSUO</creator><creator>ISHII, NOBUYA</creator><creator>PARK, MINJEONG</creator><creator>KINOSHITA, KAZUTOMO</creator><creator>FURUICHI, NORIYUKI</creator><creator>ONO, YOSHIYUKI</creator><creator>EMURA, TAKASHI</creator><creator>SAKAMOTO, HIROSHI</creator><creator>KATO, YASUHARU</creator><creator>ASOH, KOHSUKE</creator><creator>ITO, TOSHIYA</creator><creator>MORIKAMI, KENJI</creator><creator>OIKAWA, NOBUHIRO</creator><creator>HONG, WOOSANG</creator><scope>EVB</scope></search><sort><creationdate>20190731</creationdate><title>TETRACYCLIC COMPOUND</title><author>KAWADA, HATSUO ; ISHII, NOBUYA ; PARK, MINJEONG ; KINOSHITA, KAZUTOMO ; FURUICHI, NORIYUKI ; ONO, YOSHIYUKI ; EMURA, TAKASHI ; SAKAMOTO, HIROSHI ; KATO, YASUHARU ; ASOH, KOHSUKE ; ITO, TOSHIYA ; MORIKAMI, KENJI ; OIKAWA, NOBUHIRO ; HONG, WOOSANG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RS58855B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; srp</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KAWADA, HATSUO</creatorcontrib><creatorcontrib>ISHII, NOBUYA</creatorcontrib><creatorcontrib>PARK, MINJEONG</creatorcontrib><creatorcontrib>KINOSHITA, KAZUTOMO</creatorcontrib><creatorcontrib>FURUICHI, NORIYUKI</creatorcontrib><creatorcontrib>ONO, YOSHIYUKI</creatorcontrib><creatorcontrib>EMURA, TAKASHI</creatorcontrib><creatorcontrib>SAKAMOTO, HIROSHI</creatorcontrib><creatorcontrib>KATO, YASUHARU</creatorcontrib><creatorcontrib>ASOH, KOHSUKE</creatorcontrib><creatorcontrib>ITO, TOSHIYA</creatorcontrib><creatorcontrib>MORIKAMI, KENJI</creatorcontrib><creatorcontrib>OIKAWA, NOBUHIRO</creatorcontrib><creatorcontrib>HONG, WOOSANG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KAWADA, HATSUO</au><au>ISHII, NOBUYA</au><au>PARK, MINJEONG</au><au>KINOSHITA, KAZUTOMO</au><au>FURUICHI, NORIYUKI</au><au>ONO, YOSHIYUKI</au><au>EMURA, TAKASHI</au><au>SAKAMOTO, HIROSHI</au><au>KATO, YASUHARU</au><au>ASOH, KOHSUKE</au><au>ITO, TOSHIYA</au><au>MORIKAMI, KENJI</au><au>OIKAWA, NOBUHIRO</au><au>HONG, WOOSANG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TETRACYCLIC COMPOUND</title><date>2019-07-31</date><risdate>2019</risdate><abstract>A compound represented by the general Formula (I) below, or a salt or solvate thereof, which is useful as an ALK inhibitor, and is useful for prophylaxis or treatment of a disease accompanied by abnormality in ALK, for example, cancer, cancer metastasis, depression or cognitive function disorder:(meanings of the symbols that are included in the formula are as given in the specification).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; srp
recordid cdi_epo_espacenet_RS58855B1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title TETRACYCLIC COMPOUND
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A21%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KAWADA,%20HATSUO&rft.date=2019-07-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERS58855B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true